logo
Adult Treatment Panel (ATP) III Analysis
Copyright © GlobalRPh Inc., All Rights Reserved.

ATP III Calculator

This program will calculate the Framingham 10-year risk percentage as well as provide treatment guidelines based on the latest clinical data.
Age:       Gender:     Smoking status 
Systolic Blood Pressure (SBP): mmHg   
Total cholesterol:mg/dl    Triglyceride level:   
HDL: mg/dl        LDL:
    Taking medication for blood pressure?  
Are any of the following present (review factors under 1, and 2)
1) Clinical coronary heart disease (CHD): Includes history of :
  a) myocardial infarction, 
  b) unstable angina or stable angina,
  c) coronary artery procedures (angioplasty or bypass surgery), or 
  d) evidence of clinically significant myocardial ischemia.

2) CHD Risk equivalents:  includes clinical manifestations of noncoronary forms of atherosclerotic disease:  
  a) peripheral arterial disease, 
  b) abdominal aortic aneurysm, 
  c) carotid artery disease  (transient ischemic attacks or stroke of carotid origin or >50% 
      obstruction of a carotid artery), 
  d) diabetes ,
  e) 2 risk factors with 10-year risk for hard CHD >20%.
How many of the following risk factors are present if any  
    (Note: if HDL 60, subtract one from the total count).
1) Cigarette smoking
2)  Hypertension (BP 140/90 mmHg or on antihypertensive medication)
3) Low HDL cholesterol (<40 mg/dL)  
4) Family history of premature CHD  (CHD in male first degree relative <55 years; CHD in female first degree relative <65 years).
5) Age (men 45 years; women 55 years)
Metabolic Syndrome - Are at least 3 of the following present after 3 months of therapeutic lifestyle changes?  
1) Abdominal obesity (Waist circumference)
    Men:  >102 cm >40 in)
    Women: >88 cm (>35 in)
2.) Triglycerides 150 mg/dL
3.) HDL cholesterol
    Men:  <40 mg/dL
    Women: <50 mg/dL
4.) Blood pressure:  130/ 85 mmHg
5.) Fasting glucose:  110 mg/dL

References:

1) Grundy SM, Cleeman JI, Bairey Merz CN, et al, for the Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227-239.

2) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.

Disclaimer

All calculations must be confirmed before use. The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical judgement. Neither GlobalRPh Inc. nor any other party involved in the preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material.PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.   Read the disclaimer
more Career Center image description
Medical Calculators - A thru Z
Lab Values - A thru Z